quinazolines has been researched along with Adenoma in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, H; Gui, S; Jin, L; Kang, J; Liu, Q; Yuan, T; Zhang, J; Zhang, Y | 1 |
| Hudish, TM; Karoor, V; Keith, RL; Le, M; Miller, YE; Mozer, AB | 1 |
| Alferez, DG; Goodlad, RA; Ryan, AJ; Wilkinson, RW; Wright, NA | 1 |
| Clarke, AR; Maughan, TS; Shaw, PH | 1 |
| Wondisford, FE | 1 |
| Ben-Shlomo, A; Bruyette, D; Cooper, O; Fukuoka, H; Mamelak, A; Melmed, S; Ren, SG | 1 |
| Berger, FG; Davis, C; Murphy, JT; Tucker, JM | 1 |
| Alferez, D; Goodlad, RA; Mandir, N; Poulsom, R; Pyrah, IT; Ryan, AJ; Smith, NR; Watkins, AJ; Wedge, SR; Wilkinson, RW | 1 |
| Bissonnette, M; Cerda, S; Cohen, G; Dougherty, U; Fichera, A; Gong, C; Hart, J; Jagadeeswaran, S; Joseph, L; Khare, S; Little, N; Mustafi, R; Sehdev, A; Tallerico, M; Tretiakova, M; Turner, JR; Yuan, W | 1 |
| Conklin, E; Dwyer-Nield, LD; Eckhardt, SG; Fritz, JM; Gustafson, DL; Iwata, KK; Kane, S; Malkinson, AM; Redente, EF; Shroyer, RJ; Tucker, C; Zerbe, LK | 1 |
| Caine, M; Mazouz, B; Shapiro, A | 1 |
| Andress, L; Bridges, AJ; Burgart, LJ; Fry, DW; Gendler, SJ; Karnes, WE; Nelson, JM; Ritland, SR | 1 |
| Kondo, S; Morita, T | 1 |
13 other study(ies) available for quinazolines and Adenoma
| Article | Year |
|---|---|
Role of EGFL7/EGFR-signaling pathway in migration and invasion of growth hormone-producing pituitary adenomas.
Topics: Adenoma; Animals; Calcium-Binding Proteins; Cell Line, Tumor; Cell Movement; EGF Family of Proteins; Endothelial Growth Factors; Enzyme Inhibitors; ErbB Receptors; Growth Hormone-Secreting Pituitary Adenoma; Humans; Mice; Neoplasm Invasiveness; Quinazolines; Rats; RNA Interference; Signal Transduction; Tyrphostins | 2018 |
Chemoprevention of murine lung cancer by gefitinib in combination with prostacyclin synthase overexpression.
Topics: Adenoma; Animals; Antineoplastic Agents; Cadherins; Cytochrome P-450 Enzyme System; Dinoprostone; Epoprostenol; ErbB Receptors; Female; Gefitinib; Intramolecular Oxidoreductases; Lung Neoplasms; Male; Mice; Mice, Transgenic; Protein Kinase Inhibitors; Quinazolines; Rats; Signal Transduction | 2010 |
Effects of vandetanib on adenoma formation in a dextran sodium sulphate enhanced Apc(MIN/+) mouse model.
Topics: Adenoma; Animals; Antineoplastic Agents; beta Catenin; Colitis; Colonic Neoplasms; Dextran Sulfate; Disease Models, Animal; ErbB Receptors; Genes, APC; Intestine, Small; Mice; Mice, Inbred C57BL; Piperidines; Protein Kinase Inhibitors; Quinazolines; Vascular Endothelial Growth Factor Receptor-2 | 2010 |
Dual inhibition of epidermal growth factor and insulin-like 1 growth factor receptors reduce intestinal adenoma burden in the Apc(min/+) mouse.
Topics: Adenoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Down-Regulation; Drug Evaluation, Preclinical; Drug Synergism; ErbB Receptors; Gefitinib; Genes, APC; Intestinal Neoplasms; Isoxazoles; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Protein Kinase Inhibitors; Pyrimidines; Quinazolines; Receptor, IGF Type 1; Tumor Burden | 2011 |
A new medical therapy for Cushing disease?
Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Animals; ErbB Receptors; Gefitinib; Humans; Molecular Targeted Therapy; Protein Kinase Inhibitors; Quinazolines | 2011 |
EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas.
Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Adrenocorticotropic Hormone; Animals; Cell Line, Tumor; Corticosterone; Dog Diseases; Dogs; Drug Screening Assays, Antitumor; ErbB Receptors; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Molecular Targeted Therapy; Neoplasm Transplantation; Pituitary ACTH Hypersecretion; Pro-Opiomelanocortin; Promoter Regions, Genetic; Protein Kinase Inhibitors; Quinazolines; Secretory Rate; Tumor Burden | 2011 |
Raltitrexed increases tumorigenesis as a single agent yet exhibits anti-tumor synergy with 5-fluorouracil in ApcMin/+ mice.
Topics: Adenoma; Adenomatous Polyposis Coli Protein; Animals; Antineoplastic Combined Chemotherapy Protocols; Drug Synergism; Epithelial Cells; Female; Fluorouracil; Intestinal Neoplasms; Loss of Heterozygosity; Male; Mice; Mice, Inbred C57BL; Quinazolines; Thiophenes; Tumor Burden | 2004 |
Inhibiting vascular endothelial growth factor receptor-2 signaling reduces tumor burden in the ApcMin/+ mouse model of early intestinal cancer.
Topics: Adenoma; Animals; Female; Genes, APC; Intestinal Neoplasms; Intestinal Polyps; Male; Mice; Mice, Inbred C57BL; Quinazolines; RNA, Messenger; Signal Transduction; Splenomegaly; Vascular Endothelial Growth Factor Receptor-2 | 2006 |
Epidermal growth factor receptor signaling is required for microadenoma formation in the mouse azoxymethane model of colonic carcinogenesis.
Topics: Adenoma; Animals; Azoxymethane; beta Catenin; Carcinogens; Cell Transformation, Neoplastic; Colonic Neoplasms; Cyclin D1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; ErbB Receptors; Gefitinib; Genes, ras; Male; Mice; Mice, Inbred A; Mutation; Quinazolines; Signal Transduction; Up-Regulation | 2007 |
Inhibition by erlotinib of primary lung adenocarcinoma at an early stage in male mice.
Topics: Adenoma; Animals; Antineoplastic Agents; Body Weight; Disease Models, Animal; Dose-Response Relationship, Drug; ErbB Receptors; Erlotinib Hydrochloride; Female; Injections, Intraperitoneal; Lung Neoplasms; Male; Mice; Mice, Inbred Strains; Mutation; Protein Kinase Inhibitors; Proto-Oncogene Proteins p21(ras); Quinazolines; Sex Factors | 2008 |
The alpha-adrenergic blocking effect of prazosin on the human prostate.
Topics: Adenoma; Adrenergic alpha-Antagonists; Humans; Male; Muscle Contraction; Prazosin; Prostate; Prostatic Neoplasms; Quinazolines; Receptors, Adrenergic; Receptors, Adrenergic, alpha | 1981 |
Inhibition of epidermal growth factor receptor tyrosine kinase fails to suppress adenoma formation in ApcMin mice but induces duodenal injury.
Topics: Acrylamides; Adenoma; Animals; Anticarcinogenic Agents; Dose-Response Relationship, Drug; Duodenal Neoplasms; Enzyme Inhibitors; ErbB Receptors; Female; Genes, APC; Genetic Predisposition to Disease; Growth Substances; Male; Mice; Mice, Inbred C57BL; Mucins; Muscle Proteins; Neuropeptides; Peptides; Phosphorylation; Protein Biosynthesis; Quinazolines; Signal Transduction; Trefoil Factor-2; Trefoil Factor-3 | 2000 |
[Comparison of selective alpha-1 blockades for alpha-receptors in human hypertrophied prostatic adenomas].
Topics: Adenoma; Adrenergic alpha-Antagonists; Aged; Humans; Male; Piperazines; Prazosin; Prostatic Hyperplasia; Prostatic Neoplasms; Quinazolines; Radioligand Assay; Receptors, Adrenergic, alpha | 1992 |